Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 13, Issue 3, 2006, Pages 221-225

  Sinha, V R ^a   Bhinge, J R ^b   Kumria, Rachna ^c   Kumar, Manoj ^d  

^a PANJAB UNIVERSITY   (India)

^b RANBAXY RESEARCH LABORATORIES   (India)

^c Ind Swift Laboratories   (India)

^d RANBAXY LABORATORIES LTD   (India)

Author keywords

Celecoxib; Cross linked PVP; Osmogen; Potassium Chloride; Sodium Chloride; Superdisintegrant

Indexed keywords

CELECOXIB; DISINTEGRATING AGENT; POTASSIUM CHLORIDE; POVIDONE; SODIUM CHLORIDE;

ARTICLE; CANCER PREVENTION; COLON; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENTERIC COATED TABLET; IN VITRO STUDY; PRIORITY JOURNAL; STOMACH PROTECTION; SUSTAINED DRUG RELEASE; UPPER GASTROINTESTINAL TRACT; WEIGHT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CELLULOSE; COLORECTAL NEOPLASMS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; POLYETHYLENE GLYCOLS; POLYMETHACRYLIC ACIDS; POLYVINYLS; POTASSIUM CHLORIDE; PYRAZOLES; PYRROLIDINES; SODIUM CHLORIDE; SULFONAMIDES; TABLETS, ENTERIC-COATED; TECHNOLOGY, PHARMACEUTICAL;

EID: 33645276817     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540500309180     Document Type: Article

References (16)

1. Ashford, M., Fell, J., Attwood, D., et al. 1993. An in vitro investigation into the suitability of pH dependent polymers for colonic targeting. Int. J. Pharm. 91:241-245.
2. Ashford, M., and Fell, T. 1994. Targeting drugs to the colon: delivery systems for oral administration. J. Drug Target. 2:241-258.
3. Ikesue, K., Kopeckova, P., and Kopecek, J. 1991. Degradation of proteins by enzymes of the gastrointestinal tract. Proc. Int. Symp. Control. Rel. Bioact. Mater. 18:580-581.
4. Kibbe, H. 2000. Crosspovidone. In: Handbook of Pharmaceutical Excipients, ed. Kibbe, H., United Kingdom: Washingtion, American Pharmaceutical Association, 163-164.
5. Kinget, R., Kalala, W., Vervoort, L., et al. 1998. Colonic drug targeting. J. Drug Target. 6:129-149.
6. Kornblum, S.S., and Stoopak, S.B. 1973. A new tablet-disintegrating agent: cross-linked polyvinylpyrrolidone. J. Pharm. Sci. 62:43-19.
7. Lee, V. H. L. 1991. Changing needs in drug delivery. In Peptide and Protein Drug Delivery, ed. Lee, V. H. L. New York: Marcel Dekker, 1-56.
8. Leopold, C.S. 1999. Coated dosage forms for colon-specific drug delivery. Pharm. Sci Technol. Today 2:197-204.
9. Reddy, S. M., Sinha, V. R., and Reddy, D. S. 1999. Novel oral colon specific drug delivery systems for pharmacotherapy of peptides and nonpeptide drugs. Drugs Today 35:537-580.
10. Rubinstein, A. 1995. Approaches and opportunities in colon specific drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 12:101-149.
11. Sarsija, S., and Hota, A. 2000. Colon- specific drug delivery systems. Ind. J. Pharm. Sci. 62:1-8.
12. Sinha, V. R., and Kumria, R. 2001a. Colonic drug delivery: prodrug approach. Pharm. Res. 18:557-564.
13. Sinha, V. R., and Kumria, R. 2001b. Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 224:19-38.
14. Sinha V.R., and Kumria, R. 2002. Binders for colon specific drug delivery: an in vitro evaluation. Int. J. Pharm. 249:23-31.
15. Sinha V.R., and Kumria, R. 2003a. Coating polymers for colon specific drug delivery: a comparative in vitro evaluation. Acta Pharmaceutica. 53:41-47.
16. Sinha, V. R., and Kumria, R. 2003b. Microbially triggered drug delivery to the colon. Eur. J. Pharm. Sci. 18:3-18.